In vitro activity of protegrin-1 and beta-defensin-1, alone and in combination with isoniazid, against Mycobacterium tuberculosis

Peptides

Volumn 25, Issue 7, 2004, Pages 1075-1077

  Fattorini, Lanfranco ^a   Gennaro, Renato ^b   Zanetti, Margherita ^c,d   Tan, Dejiang ^a   Brunori, Lara ^a   Giannoni, Federico ^a   Pardini, Manuela ^a   Orefici, Graziella ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c UNIVERSITY OF UDINE   (Italy)

^d Laboratorio Nazionale CIB   (Italy)

Author keywords

Activity in vitro; Human beta defensin 1; Isoniazid; Mycobacterium tuberculosis; Protegrin 1

Indexed keywords

BETA DEFENSIN 1; ISONIAZID; PROTEGRIN; PROTEGRIN 1; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SENSITIVITY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; DRUG SYNERGISM; HUMANS; ISONIAZID; MYCOBACTERIUM TUBERCULOSIS; PROTEINS;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 3042737036     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2004.04.003     Document Type: Article

References (14)

1. Circo R., Skerlavaj B., Gennaro R., Amorosa A., Zanetti M. Structural and functional characterization of hBD-1(ser35), a peptide deduced from a DEFB1 polymorphism. Biochem. Biophys. Res. Commun. 293:2002;586-592
2. Fattorini L., Tan D., Iona E., Mattei M., Giannoni F., Brunori L., et al. Activities of moxifloxacin alone and in combination with other antimicrobial agents against multidrug-resistant Mycobacterium tuberculosis infection in BALB/c mice. Antimicrob. Agents Chemother. 47:2003;360-362
3. Gennaro R., Zanetti M. Structural features and biological activities of the cathelicidin-derived antimicrobial peptides. Biopolymers. 55:2000;31-49
4. Hoover D.M., Chertov O., Lubkowski J. The structure of human beta-defensin-1: new insights into structural properties of beta-defensins. J. Biol. Chem. 276:2001;39021-39026
5. Iwainsky H. Mode of action, biotransformation, and pharmacokinetics of antituberculosis drugs in animals and man. Hand Exp. Pharmacol. 84:1988;399-553
6. Jia H.P., Starner T., Ackermann M., Kirby P., Tack B.F., McCray P.B. Jr. Abundant human beta-defensin-1 expression in milk and mammary gland epithelium. J. Pediatr. 138:2001;109-112
7. Linde C.M., Hoffner S.E., Refai E., Andersson M. In vitro activity of PR-39 a proline-arginine-rich peptide against susceptible and multi-drug-resistant Mycobacterium tuberculosis. J. Antimicrob. Chemother. 47:2001;575-580
8. Miyakawa Y., Ratnakar P., Rao A.G., Costello M.L., Mathieu-Costello O., Lehrer R.I., et al. In vitro activity of the antimicrobial peptides human and rabbit defensins and porcine leukocyte protegrin against Mycobacterium tuberculosis. Infect. Immun. 64:1996;926-932
9. Sharma S., Verma I., Khuller G.K. Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis. Antimicrob. Agents Chemother. 45:2001;639-640
10. Shi J., Zhang G., Wu H., Ross C., Blecha F., Ganz T. Porcine epithelial beta-defensin 1 is expressed in the dorsal tongue at antimicrobial concentrations. Infect. Immun. 67:1999;3121-3127
11. Singh P.K., Jia H.P., Wiles K., Hesselberth J., Liu L., Conway B.A., et al. Production of beta-defensins by human airway epithelia. Proc. Natl. Acad. Sci. U.S.A. 95:1998;14961-14966
12. Sokolov Y., Mirzabekov T., Martin D.W., Lehrer R.I., Kagan B.L. Membrane channel formation by antimicrobial protegrins. Biochim. Biophys. Acta. 1420:1999;23-29
13. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 415:2002;389-395
14. Zhang Y, Telenti A. Genetics of drug resistance in Mycobacterium tuberculosis. In: Hatfull GF, Jacobs WR Jr, editors. Molecular genetics of mycobacteria. American Society for Microbiology Press, 2000. p. 235-54.